People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

7.00CAD
31 Oct 2014
Price Change (% chg)

$-0.06 (-0.85%)
Prev Close
$7.06
Open
$7.00
Day's High
$7.00
Day's Low
$7.00
Volume
133
Avg. Vol
1,578
52-wk High
$9.25
52-wk Low
$4.50

Search Stocks

Cruz, Tony 

Brief Biography

Dr. Tony Cruz is Chairman of the Board, Chief Executive Officer of Transition Therapeutics Inc. Dr. Cruz is one of the founders of Transition Therapeutics and has held the position of Chief Executive Officer of Transition Therapeutics since its inception in July 1998. Dr. Cruz was a Co-Founder, Vice-President and Director at Angiotech Pharmaceuticals Inc. Dr. Cruz has been a Senior Scientist at Mount Sinai Hospital since 1995 and was the CEO and President of the Canadian Arthritis Network until 2001. He has also served as a consultant for biotechnology companies and investment firms.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
423,300 -- 1,576 424,876

Options Compensation

  Quantity Market Value
Exercisable 132,871 599,213.00
Unexercisable 333,796 342,120.00
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Nicole Rusaw

316,054

Carl Damiani

319,775

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of 29 Jun 2013
Search Stocks